MEDINET Co., Ltd. (TSE: 2370)
Health Care · Life Sciences Tools & Services · JP
¥23.00
-4.17% today · -32.4% 1Y
MEDINET Co., Ltd. (TSE: 2370) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $41.20M and employs 107 people.
Over the last twelve months the share price has lost 32.4%, trading between 23.00 and 43.00.
Tweenvest scores MEDINET Co., Ltd. across four factors: quality 50/100, value 39/100, growth 0/100. Its strongest factor is quality.
2370 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $41.20M
- Revenue (TTM)
- $8.79M
- P/E
- —
- EPS
- -26.77
- Dividend yield
- —
- Beta (5Y)
- 0.40
- 52-week high
- ¥43.00
- 52-week low
- ¥23.00
- Avg volume (3M)
- —
- Shares outstanding
- 283.67M
- Employees
- 107
- Next earnings
- —
About MEDINET Co., Ltd.
Established in 1995 and headquartered in Tokyo, Japan, MEDINET Co., Ltd. functions as a contract development and manufacturing organization (CDMO) primarily focused on regenerative medicine and cell therapy solutions within Japan. The company furnishes comprehensive support for immuno-cell therapy, encompassing critical elements such as specialized technical expertise, advanced facilities, robust operational systems, essential materials, and skilled cell engineers. Furthermore, MEDINET actively manufactures regenerative medical products, investigational cell products, and other specified cell-based therapies. Its extensive value chain offerings also cover personnel training, facility and equipment design, operational management, standard operating procedure (SOP) preparation, logistics networks, information systems, purchasing and production management, stringent quality management and assurance, and technology transfer and process development. The firm actively collaborates with and supports medical institutions, research organizations, and biopharmaceutical companies in their endeavors to advance immuno-cell therapy.
- ISIN
- JP3920990003
- Founded
- 1995
- Listed since
- Oct 8, 2003
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rapid Micro Biosystems, Inc.NasdaqCM: RPID | $44.82M | $0.89 | -2.88% |
| Abnova (Taiwan) CorporationTWSE: 4133 | $42.89M | NT$22.65 | +10.76% |
| Eone Diagnomics Genome Center Co., Ltd.KOSDAQ: A245620 | $42.41M | ₩— | — |
| Macter International LimitedKASE: MACTER | $41.22M | PKRs249.15 | -1.90% |
| QuadMedicine, Inc.KOSDAQ: A464490 | $41.08M | ₩4,810.00 | -6.60% |
| Cryosite LimitedASX: CTE | $41.04M | AU$1.21 | +4.78% |
| Precision System Science Co., Ltd.TSE: 7707 | $40.24M | ¥232.00 | +9.43% |
| WDB coco Co., Ltd.TSE: 7079 | $39.64M | ¥2,610.00 | -0.46% |
Figures last refreshed Oct 11, 2026.